The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-7-(2,2-difluoro-1-phenylethyl)-5,5-dimethyl-2-(phenylamino)-5H-pyrrolo[2,3-d]pyrimidin-6(7H)-one ID: ALA3885257
PubChem CID: 134130107
Max Phase: Preclinical
Molecular Formula: C22H20F2N4O
Molecular Weight: 394.43
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CC1(C)C(=O)N([C@H](c2ccccc2)C(F)F)c2nc(Nc3ccccc3)ncc21
Standard InChI: InChI=1S/C22H20F2N4O/c1-22(2)16-13-25-21(26-15-11-7-4-8-12-15)27-19(16)28(20(22)29)17(18(23)24)14-9-5-3-6-10-14/h3-13,17-18H,1-2H3,(H,25,26,27)/t17-/m1/s1
Standard InChI Key: HUHRXBBSMSZINZ-QGZVFWFLSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
4.1396 -19.6250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0347 -21.6019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4474 -20.8962 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6299 -20.8916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0557 -22.2646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7638 -22.6735 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.4734 -22.2641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4706 -21.4414 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.0569 -21.4450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7641 -21.0354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5931 -20.2361 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.7800 -20.1518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9403 -19.7986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3714 -19.4441 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1818 -22.6716 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8888 -22.2619 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5939 -22.6698 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3004 -22.2608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2996 -21.4427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5863 -21.0354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8826 -21.4468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1899 -20.5786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9892 -20.7497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5382 -20.1419 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2823 -19.3603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4837 -19.1929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8874 -18.8477 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4344 -18.2406 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.0881 -18.6775 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3 2 1 0
4 3 1 0
9 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 10 2 0
9 10 1 0
10 11 1 0
11 12 1 0
12 3 1 0
3 9 1 0
1 13 1 0
11 1 1 0
12 14 2 0
7 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
13 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 13 1 0
1 27 1 1
27 28 1 0
27 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 394.43Molecular Weight (Monoisotopic): 394.1605AlogP: 4.85#Rotatable Bonds: 5Polar Surface Area: 58.12Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.07CX Basic pKa: 0.73CX LogP: 5.08CX LogD: 5.08Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.67Np Likeness Score: -0.80
References 1. Katz JD, Haidle A, Childers KK, Zabierek AA, Jewell JP, Hou Y, Altman MD, Szewczak A, Chen D, Harsch A, Hayashi M, Warren L, Hutton M, Nuthall H, Su HP, Munshi S, Stanton MG, Davies IW, Munoz B, Northrup A.. (2017) Structure guided design of a series of selective pyrrolopyrimidinone MARK inhibitors., 27 (1): [PMID:27816515 ] [10.1016/j.bmcl.2016.08.068 ]